• WHY HOUSE OF DEEPTECH?

    Founders First. Professionals Only. No Vultures. No Egos. Inclusive Always.

  • MARKET ACCESS

    Customised go to market and scale-up program that is tailored to your Company's European growth objectives.

    MARKET ENTRY STRATEGY

    Customer Experience based Market Adaptation delivering support for adaptations to package, pricing, transaction, access, support, channels & programs.

    CUSTOMER CONNECT

    Accelerated access to meet with prospective Clients, Partners, Distributors, and Resellers. Boot camp market entry strategies and logistics.

    FUND RAISING SUPPORT

    Introductions to participating VC's and Corporates. Increased brand awareness and opportunities for business expansion and M&A.
     

  • ECOSYSTEM CONNECT

    Soft landing into Singapore and Luxembourg ecosystems, accelerating access to the APAC and European market. Efficient company setup, banking, accounting and secretarial support.

    TECH PERKS

    Access to millions of dollars in cloud credits and discounts from our supporting perk partners.

  • FROM OUR FOUNDERS

    Rachel Hong, Cofounder of Meracle Health

    Rachel Hong

    COFOUNDER MERACLE HEALTH

    Our one on one coaching at the House of X has helped to propel us forward in multiple aspects of our business. Through their vast network in the MedTech space, we have connected to relevant partners and advisors with a broad range of capabilities. The team has been instrumental in helping us articulate our market entry strategy and expand our access to the European market. True to their mission of founders first, the direction the team provided focused on adding value by achieving critical milestones.

    Dr Jeremy Ting, CEO of Naluri Life

    Dr Jeremy Ting

    COFOUNDER NALURI LIFE

    "Through the House of X incubation program, we have been privileged and grateful to have forged a working relationship with an esteemed PI at the Luxembourg Institute of Health, to validate our digital solution in the context of diabetes prevention. This now puts us on a path to secure CE Mark regulatory approval, accelerate our access to non-dilutive and smart capital, and firmly positions our European HQ for international scale."

  • DELIVERING ECONOMIC IMPACT VIA OUTCOMES

    R3i's deeptech and medtech growth platforms and soft landing pads in Singapore and Luxembourg are driving economic impact. We do this through the delivery of 3 core benefits: commercialization, capitalization and R&D pathways.

     

    This results in talent attraction and local employment, co-development of intellectual property to build out our

    smart city, deeptech and medtech ecosystems, and the generation of outcomes for economic impact.

    Talent & Employment

    Accelerated immigration pathways available to soft land and expand your deeptech or medtech pioneers into the Asia Pacific and Europe via Singapore and Luxembourg.

    Intellectual Property

    Co-create with world leading research institutes for the last mile CE mark clinical study and health economics or accelerate your R&D roadmap to invent new IP or rapidly test and commercialise or unlock the value of your Intellectual Property.

    Economic Impact

    Through rapid commercialisation and capitalization, our founders generate impact. For ever $1 generated by our founders in revenues alone, they can generate up to $1.80 into their local ecosystem via direct flow-on supply chain or consumption effects.

HOME
CORE BENEFITS
PARTNERS
PERK PARTNERSHIP
NAVIGATORS
CONTACT
Privacy Policy
House of X Pte Ltd 2022 © All rights reserved. UEN 202108109R​ 
10 Anson Road #26-08,
International Plaza, Singapore 079903
 
Republication or redistribution of House of X content, including by framing or similar means, is prohibited without the prior written consent of R3i Ventures. House of DeepTech, House of MedTech, House of X, and R3i Ventures and their logos, as well as all other trademarks used herein, are trademarks of their respective owners and used under license.
Terms & Conditions
Privacy Policy
    All Posts
    ×
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More